1. Home
  2. GKOS vs THO Comparison

GKOS vs THO Comparison

Compare GKOS & THO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • THO
  • Stock Information
  • Founded
  • GKOS 1998
  • THO 1980
  • Country
  • GKOS United States
  • THO United States
  • Employees
  • GKOS N/A
  • THO N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • THO Homebuilding
  • Sector
  • GKOS Health Care
  • THO Industrials
  • Exchange
  • GKOS Nasdaq
  • THO Nasdaq
  • Market Cap
  • GKOS 5.8B
  • THO 5.1B
  • IPO Year
  • GKOS 2015
  • THO N/A
  • Fundamental
  • Price
  • GKOS $94.32
  • THO $95.34
  • Analyst Decision
  • GKOS Strong Buy
  • THO Hold
  • Analyst Count
  • GKOS 12
  • THO 10
  • Target Price
  • GKOS $134.67
  • THO $85.44
  • AVG Volume (30 Days)
  • GKOS 869.3K
  • THO 604.9K
  • Earning Date
  • GKOS 07-30-2025
  • THO 06-04-2025
  • Dividend Yield
  • GKOS N/A
  • THO 2.10%
  • EPS Growth
  • GKOS N/A
  • THO N/A
  • EPS
  • GKOS N/A
  • THO 4.17
  • Revenue
  • GKOS $404,523,000.00
  • THO $9,589,874,000.00
  • Revenue This Year
  • GKOS $27.88
  • THO N/A
  • Revenue Next Year
  • GKOS $27.60
  • THO $4.15
  • P/E Ratio
  • GKOS N/A
  • THO $22.85
  • Revenue Growth
  • GKOS 23.92
  • THO N/A
  • 52 Week Low
  • GKOS $77.10
  • THO $63.16
  • 52 Week High
  • GKOS $163.71
  • THO $118.85
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 37.61
  • THO 61.71
  • Support Level
  • GKOS $92.42
  • THO $92.76
  • Resistance Level
  • GKOS $98.21
  • THO $97.32
  • Average True Range (ATR)
  • GKOS 2.85
  • THO 2.59
  • MACD
  • GKOS -1.10
  • THO 0.11
  • Stochastic Oscillator
  • GKOS 13.19
  • THO 79.28

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About THO Thor Industries Inc.

Based in Elkhart, Indiana, Thor Industries manufactures Class A, Class B, and Class C motor homes along with travel trailers and fifth-wheel towables across about 35 brands. Through the acquisition of Erwin Hymer in 2019, the company expanded its geographic footprint and now produces various motorized and towable recreational vehicles for Europe, including motor caravans, camper vans, urban vehicles, caravans, and other RV-related products and services. The company has also begun generating revenue through aftermarket component parts via the acquisition of Airxcel in 2021; however, this is still a nascent part of the business as it accounts for less than 10% of total sales. In fiscal 2024, the company wholesaled 186,908 units and generated over $10 billion in revenue.

Share on Social Networks: